Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: Results from the randomised, placebo-controlled avodart after radical therapy for Prostate Cancer Study (ARTS)

1. Schröder, F.
2. Bangma, C.
3. Angulo, J.C.
4. Alcaraz, A.
5. Colombel, M.
6. McNicholas, T.
7. Tammela, T.L.
8. Nandy, I.
9. Castro, R.